NCT04203706 is a NA clinical trial of Neurofunctional imaging in Food Oriented Behavior, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

Who is sponsoring NCT04203706?

NCT04203706 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

What drugs are being tested in NCT04203706?

Interventions in NCT04203706: Neurofunctional imaging.

What condition does NCT04203706 study?

NCT04203706 studies Food Oriented Behavior.

Is NCT04203706 still recruiting?

NCT04203706 is currently status unknown. Last updated 18 December 2019.

Last reviewed 2019-12-18 · How we verify

NCT04203706

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Behavioral and Neurofunctional Correlates of Intentional Motor Behaviors Towards Edible Stimuli in Normal-weight Subjects

Status unknown NA Last updated 18 December 2019

What this trial tests

NA trial testing Neurofunctional imaging in Food Oriented Behavior in 48 participants. Status unknown.

Timeline

1 February 2020

Primary endpoint
1 February 2021

31 January 2023

Quick facts

Lead sponsor	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	48
Start date	1 February 2020
Primary completion	1 February 2021
Estimated completion	31 January 2023

Drugs / interventions tested

Neurofunctional imaging

Conditions studied

Food Oriented Behavior — all drugs for Food Oriented Behavior →

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

Adults 18 to 80, any sex, with Food Oriented Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate, through behavioural tests combined with advanced neurofunctional methods, the neural bases of intentional behaviours towards edible stimuli using explicit and implicit paradigms in normal-weight subjects. This knowledge will then be expanded with the study of associations between behavioral/neurofunctional measures and blood/hummon parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

NCT07386405 — Validation and Cultural Adaptation of the KOOS-ACL Scale for the Italian Population · not yet recruiting
NCT07352111 — High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction · NA · recruiting
NCT07304323 — Prepare II - Predictive Model Training and External Validation · recruiting
NCT07337499 — Comparison of Maglumi X3 SNIBE With Other Analytical Methods in Laboratory Medicine for 25-(OH)D Quantification · recruiting
NCT06940245 — Use of Virtual Reality for the Assessment of Attentional and Reaction Abilities for Fall Risk Evaluation · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04203706 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Last refreshed: 18 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04203706.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing